Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)

$BZHPress releaseSep 9, 2026, 8:03 AM ETRead the release

Brodsky & Smith issued a shareholder notice announcing investigations into four pending mergers, including Beazer Homes' agreement to be acquired by Dream Finders Homes for $33.50 per share in cash at an enterprise value of approximately $2.2 billion. The firm says it is probing whether the Beazer board breached fiduciary duties by failing to conduct a fair process or secure fair value, and invites shareholders to contact the attorneys at no cost or obligation. The same notice bundles near-identical investigations into Personalis' $1.5 billion sale to Tempus AI, Werewolf Therapeutics' merger with Ambros Therapeutics, and MarketAxess' roughly $6.0 billion sale to Intercontinental Exchange.

Key figures

Deal Value Usd
2200000000
Deal structure
all-cash
Merger price per share
$33.50
Marketaxess equity value
$6.0 billion
Ambros combined ownership
71.7%
Personalis per share price
$16.25
Marketaxess per share price
$167 per share
Personalis enterprise value
$1.5 billion
Werewolf combined ownership
6.8%
Marketaxess enterprise value
$5.7 billion

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.